APITBIO CO., LTD
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
APITBIO CO., LTD - overview
Established
2018
Location
Seoul, -, South Korea
Primary Industry
Biotechnology
About
Based in Seoul, South Korea, and founded in 2018 by CEO Seon-Joo Yoon, APITBIO CO. , LTD. provides a platform to research and develop antibody-based therapeutics. In February 2021, Apitbio Co.
, Ltd. raised KRW 14 billion in series A funding from UTC Investment, LSK Investment, KDB Capital, Mirae Equity Partners, Laguna Investment, Hyundai Technology Investment, KB Securities, Kolon Investment, and Shinhan Venture Investment. APITBIO develops antibody-based innovative anticancer drugs such as monoclonal antibodies and double antibodies through research and develops innovative antibody therapeutics from screening and discovery to optimization and production, thus helping hospitals treat the unmet medical needs of patients. The company uses a one-stop system antibody library to generate candidate antibodies optimized for new targets for generating antibodies in sufficient quantities to test for preliminary toxicity in primates.
As of April 2023, the firm is in phase 1 of developing a monoclonal, bispecific, and CAR-T pipeline.
Current Investors
Hyundai Venture Investment , Shinhan Venture Investment, KDB Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Biotechnology, Pharmaceutical Research & Development, Specialty Pharmaceuticals
Website
www.apitbio.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.